Article Versions Notes

Matsumoto K, Nishida T, Nakamatsu D, Yamamoto M, Fukui K, Morimura O, Abe K, Okauchi Y, Iwahashi H, Inada M. An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19. Clinics and Practice. 2024; 14(4):1601-1614. https://doi.org/10.3390/clinpract14040129

Matsumoto, Kengo, Tsutomu Nishida, Dai Nakamatsu, Masashi Yamamoto, Koji Fukui, Osamu Morimura, Kinya Abe, Yukiyoshi Okauchi, Hiromi Iwahashi, and Masami Inada. 2024. "An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19" Clinics and Practice 14, no. 4: 1601-1614. https://doi.org/10.3390/clinpract14040129

Matsumoto, K., Nishida, T., Nakamatsu, D., Yamamoto, M., Fukui, K., Morimura, O., Abe, K., Okauchi, Y., Iwahashi, H., & Inada, M. (2024). An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19. Clinics and Practice, 14(4), 1601-1614. https://doi.org/10.3390/clinpract14040129